KalVista Pharmaceuticals, Inc. KALV
Set alert
27.00 USD 0.00 0.00%
At close · Jun 10
26.99 -0.01 -0.04%
After hours · Jun 10, 4:00 PM ET
26.98 Day range 27.00
9.83 52-week range 27.00
- YTD
- +67.18%
- 1 year
- +106.26%
- Open
- 26.99
- Prev close
- 27.00
- Mkt cap
- 1.44B
- Vol
- 4.26M
- Avg vol
- 3.63M
- EPS
- -3.94
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.98
- High
- 27.00
- Forward P/E
- 15.82
- Beta
- -0.11
- Short ratio
- 0.94
- Inst. own
- 136.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 3, 2026
- 50-d avg
- 24.43
- 200-d avg
- 17.09
- 1y target
- 27.00
Financial health
Altman Z-Score
-0.51 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -5.0×
FY 2017 5y median -3.7× FY 2026
P/S 11.2×
FY 2017 5y median 0.0× FY 2026
P/B -303×
FY 2017 5y median 1.7× FY 2026
P/FCF -9.9×
FY 2017 5y median -4.5× FY 2026
EV/EBITDA -4.9×
FY 2017 5y median -3.4× FY 2026
EV/Sales 10.1×
FY 2017 5y median 0.0× FY 2026
FCF Yield -10.1%
FY 2017 5y median -22.4% FY 2026
Profitability
Gross Margin 91.7%
FY 2017 5y median 0.0% FY 2026
Operating Margin -233.4%
FY 2017 5y median 0.0% FY 2026
Net Margin -223.2%
FY 2017 5y median 0.0% FY 2026
ROE 6060.0%
FY 2017 5y median -57.7% FY 2026
ROIC -58.9%
FY 2017 5y median -61.6% FY 2026
ROA -49.0%
FY 2017 5y median -50.7% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2026
Operating Income 8.6%
FY 2017 FY 2026
EPS (diluted) 12.5%
FY 2017 FY 2026
Free Cash Flow 45.7%
FY 2017 FY 2026
Financial Health
Current Ratio 5.6×
FY 2017 5y median 9.9× FY 2026
Quick Ratio 5.5×
FY 2017 5y median 9.9× FY 2026
Debt / Equity -55.9×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.5×
FY 2017 5y median 0.5× FY 2026
Interest Coverage -8.9×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2025-12-31